Taro Pharmaceutical Industries (TARO), a maker of generic drugs, has all the hallmarks of a beautifully underfollowed gem: a boring business, a horrible website, coverage by a single analyst, few Seeking Alpha followers, a blizzard of irrelevant SEC filings hiding the useful documents, and zero self-promotion. Want flashy presentations telling you in a few pithy slides exactly how the business functions? Don't expect it from Taro. Nevertheless, despite appreciating dramatically since the prescient articles found here and here by Retail Investor, Taro has a wonderful business with good long-term growth prospects. For serious investors who believe that making money is more important than having conversation-starters available for cocktail parties, Taro is a reasonable and conservative investment with a...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|